Leveraged Finance Fights Melanoma

The Leveraged Finance Fights Melanoma benefit and cocktail party is planned for Wednesday, May 23, at the Summer Garden at Rockefeller Center in Midtown Manhattan. Tickets and sponsorship opportunities are available at the Melanoma Research Alliance website:www.curemelanoma.org/lffm.

Funds raised at the event will support the Melanoma Research Alliance (MRA), the world’s largest private funder of melanoma research, which was founded in 2007 by Debra and Leon Black, under the auspices of the Milken Institute.

Since this event was launched in 2012, the leveraged finance community has come together and generously supported more than $8.6 million of cutting-edge research to make transforming advances in the prevention, diagnosis and staging, and treatment of melanoma.

This year, LFFM welcomes two new co-chairs to the event committee: AJ Murphy (BAML) and Geoff Oltmans (Silver Lake). AJ and Geoff join returning event co-chairs Brendan Dillon (UBS); Lee Grinberg (Elliott Management); George Mueller (KKR); Jeff Rowbottom (PSP Investments); Cade Thompson (KKR); and Trevor Watt (Hellman & Friedman).

2017 Leveraged Finance Fights Melanoma at the Rockefeller Center’s Summer Garden

Attendees include the biggest names in leveraged finance, from all of the top banks, many investment houses, several law firms, select issuers, and some private equity sponsors.

Kirkland & Ellis is a presenting sponsor. Platinum sponsors include Apollo; Bloomberg; Fitch Ratings; IPREO Debtdomain; Midcap Financial; PSP Investments; Simpson Thacher & Bartlett; and UBS. Gold sponsors are Block Communications; Cahill Gordon & Reindel; Carlyle Group; Guggenheim; Hellman & Friedman; Latham & Watkins; Macquarie; Milbank Tweed Hadley & McCloy; Mizuho Americas; Oaktree Capital; Shearman & Sterling; Skadden, Arps, Slate, Meagher & Flom; T. Rowe Price, Wells Fargo, and Weil Gotshal. For a full listing of sponsors, please visitwww.curemelanoma.org/lffm.

Due to ongoing operational support from its founders, 100% of donations to MRA go directly to support research programs working toward a cure for melanoma, the deadliest type of skin cancer. Since MRA began its work, 11 new treatments have been approved by the FDA. Research performed in the melanoma field continues to have rippling impacts in the whole oncology space.

The data that MRA-funded scientists are generating is informing research in over 30 cancers, including colon, breast, brain, pancreatic, kidney, prostate, bladder, leukemia, lymphoma, and lung. Tickets are $300. For further information about the event and to purchase tickets, please visitwww.curemelanoma.org/lffm.

Those seeking information about the event and sponsorship opportunities can contact Rachel Gazzerro of MRA at (202) 336-8947 or RGazzerro@curemelanoma.org.

Melanoma Research Alliance
Founded in 2007 under the auspices of the Milken Institute, with the generous support of Debra and Leon Black, the Melanoma Research Alliance exists to accelerate treatment options and find a cure for melanoma. As the largest nonprofit funder of melanoma research, it has dedicated $100 million and leveraged more than $90 million in addition towards its mission. Through its support, MRA has championed revolutions in immunotherapy, targeted therapies, novel combinations and diagnostics. Due to the ongoing support of its founders, 100 percent of donations to MRA go directly to its melanoma research program. MRA’s ability to fund wide-ranging research in melanoma is amplified by unique collaborations and partnerships with individuals, private foundations, and corporations (www.CureMelanoma.org).

© 2018 Private Equity Professional | May 2, 2018

Print Friendly, PDF & Email

Related Articles

Abacus Backs River’s Buy of GAHH Abacus Finance Group was the Administrative Agent and Lead Arranger for $22 million in senior secured credit facilities to support the recent acquisit...
New Partner at Trive Capital Trive Capital has promoted Blake Bonner to Partner. Mr. Bonner’s responsibilities include identifying and evaluating investment opportunities, perform...
Genstar Promotes Two Genstar Capital has promoted Geoff Miller to Director and Rob Clark to Principal. “We are pleased to announce the promotions of Geoff and Rob,” sai...
New Managing Director at Grey Mountain Grey Mountain Partners has promoted Beth Lesniak to Managing Director. Ms. Lesniak joined Grey Mountain in 2009 and she is active in all areas of t...
The Seller’s Market Continues High valuations and abundant use of debt continued to mark completed deal activity in the first quarter of 2018, according to GF Data’s just-released ...
Drew Meyers Rejoins Seaport Seaport Capital has added Drew Meyers to its investment team as a new partner. Mr. Meyers previously worked at Seaport from 2001 to 2007. We are ex...